Astrana Health (NASDAQ:ASTH) Releases FY24 Earnings Guidance

Astrana Health (NASDAQ:ASTH) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $1.28 to $1.52 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Stifel Nicolaus decreased their price objective on Astrana Health from $50.00 to $45.00 and set a buy rating for the company in a report on Wednesday. Jefferies Financial Group started coverage on Astrana Health in a report on Monday, February 26th. They set a buy rating and a $50.00 target price for the company. Finally, Truist Financial lifted their target price on Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a report on Friday, March 1st.

Astrana Health Trading Down 0.4 %

Shares of NASDAQ:ASTH traded down $0.15 during trading on Friday, reaching $38.90. 50,359 shares of the company traded hands, compared to its average volume of 152,774. The stock has a market capitalization of $2.18 billion, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. Astrana Health has a 52-week low of $28.86 and a 52-week high of $45.71. The company has a quick ratio of 2.11, a current ratio of 2.11 and a debt-to-equity ratio of 0.42. The firm’s fifty day simple moving average is $40.12.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The business had revenue of $404.36 million for the quarter, compared to the consensus estimate of $413.84 million. During the same quarter in the prior year, the company earned $0.42 EPS. Astrana Health’s revenue was up 19.9% compared to the same quarter last year. On average, sell-side analysts predict that Astrana Health will post 1.65 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.